Familial and sporadic porphyria cutanea tarda: Clinical, biochemical and genetic features with emphasis on iron status

Acta Dermato-Venereologica

Volumn 83, Issue 2, 2003, Pages 115-120

  Bygum, Anette ^a   Christiansen, Lene ^a   Petersen, Niels Erik ^a   Hørder, Mogens ^a   Thomsen, Kristian ^b   Brandrup, Flemming ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

Author keywords

Genetics; Haemochromatosis; Phenotype; Porphyria cutanea tarda; Uroporphyrinogen decarboxylase gene mutations

Indexed keywords

ALCOHOL; DNA; ESTROGEN; IRON; PORPHYRIN; UROPORPHYRIN; UROPORPHYRINOGEN DECARBOXYLASE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; FEMALE; GENE; GENE MUTATION; GENOTYPE; HEMOCHROMATOSIS; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL;

ADULT; AGED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEMOCHROMATOSIS; HUMANS; IRON; MALE; MIDDLE AGED; PORPHYRIA CUTANEA TARDA; UROPORPHYRINOGEN DECARBOXYLASE;

EID: 0037259260     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/00015550310007454     Document Type: Article

References (29)

1. Waldenström J. Studien über Porphyrie. Acta Med Scand 1937; Suppl. 82: 84-90.
2. Elder GH. Porphyria cutanea tarda. Semin Liver Dis 1998; 18: 67-75.
3. Murphy GM. The cutaneous porphyrias: a review. Br J Dermatol 1999; 140: 573-581.
4. Kushner JP, Edwards CQ, Dadone MM, Skolnick MH. Heterozygosity for HLA-linked hemochromatosis as a likely cause of the hepatic siderosis associated with sporadic porphyria cutanea tarda. Gastroenterology 1985; 88: 1232-1238.
5. Kappas A, Sassa S, Galbraith RA, Nordmann Y. The porphyrias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited diseases. New York: McGraw-Hill, 1995: 2129-2135.
6. Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH. Increased frequency of the haemochromatosis Cys282 Tyr mutation in sporadic porphyria cutanea tarda. Lancet 1997; 349: 321-323.
7. Christiansen L, Bygum A, Thomsen K, Brandrup F, Hørder M, Petersen NE. Denaturing gradient gel electrophoresis analysis of the hemochromatosis (HFE) gene: Impact of HFE gene mutations on the manifestation of porphyria cutanea tarda. Clin Chem 1999; 45: 2025-2026.
8. Herrero C, Vicente A, Bruguera M, Ercilla MG, Barrera JM, Vidal J, et al. Is hepatitis C virus infection a trigger of porphyria cutanea tarda. Lancet 1993; 341: 788-789.
9. Stölzel U, Köstler E, Koszka C, Stöffler-Meilicke M, Schuppan D, Somasundaram R, et al. Low prevalence of hepatitis C virus infection in porphyria cuanea tarda in Germany. Hepatology 1995; 21: 1500-1503.
10. Ash S, Woodley DT, Chan LS. Porphyria cutanea tarda preceding AIDS. Lancet 1996; 347: 190.
11. Siersema PD, ten Kate FJW, Mulder PGH, Wilson JHP. Hepatocellular carcinoma in porphyria cutanea tarda: frequency and factors related to its occurrence. Liver 1992; 12: 56-61.
12. de Verneuil H, Aitken G, Nordmann Y. Familial and sporadic porphyria cutanea. Two different diseases. Hum Genet 1978; 44: 145-151.
13. Elder GH, Roberts AG, de Salamanca RE. Genetics and pathogenesis of human uroporphyrinogen decarboxylase defects. Clin Biochem 1989; 22: 163-168.
14. Moran-Jimenez MJ, Ged C, Romana M, de Salamanca RE, Teïeb A, Topi G, et al. Uroporphyrinogen decarboxylase: complete human gene sequence and molecular study of three families with hepatoerythropoietic porphyria. Am J Hum Genet 1996; 58: 712-721.
15. Christiansen L, Bygum A, Jensen A, Brandrup F, Thomsen K, Høder M, et al. Uroporphyrinogen decarboxylase gene mutations in Danish patients with porphyria cutanea tarda. Scand J Clin Lab Invest 2000; 60: 611-615.
16. McManus J, Blake D, Ratnaike S. An assay of uroporphyrinogen decarboxylase in erythrocytes. Clin Chem 1988; 34: 2355-2357.
17. Doss MO, Frank M, Braun-Falco O. Porphyria cutanea tarda: erythrocyte uroporphyrinogen decarboxylase activity in 471 consecutive patients. Curr Probl Dermatol 1991; 20: 97-105.
18. Held JL, Sassa S, Kappas A, Harber LC. Erythrocyte uroporphyrinogen decarboxylase activity in porphyria cutanea tarda: a study of 40 consecutive patients. J Invest Dermatol 1989; 93: 332-334.
19. Siersema PD, Rademakers LH, Cleton MI, ten Kate FJW, de Bruijn WC, Marx JJM, et al. The difference in liver pathology between sporadic and familial forms of porphyria cutanea tarda: the role of iron. J Hepatol 1995; 23: 259-267.
20. Kószó F, Morvay M, Dobozy A, Simon N. Erythrocyte uroporphyrinogen decarboxylase activity in 80 unrelated patients with porphyria cutanea tarda. Br J Dermatol 1992; 126: 446-449.
21. Bruguera M. Liver involvement in porphyria. Semin Dermatol 1986; 5: 178-185.
22. Kordac V. Frequency of occurrence of hepatocellular carcinoma in patients with porphyria cutanea tarda in long-term follow-up. Neoplasma 1972; 19: 135-139.
23. Lim HW, Mascaro JM. The porphyrias and hepatocellular carcinoma. Dermatol Clin 1995; 13: 135-142.
24. Bonkovsky HL, Poh-Fitzpatrick M, Pimstone N, Obando J, Di Bisceglie A, Tattrie C, et al. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America. Hepatology 1998; 27: 1661-1669.
25. Bulaj ZJ, Phillips JD, Ajioka RS, Franklin MR, Griffen LM, Guinee DJ, et al. Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda. Blood 2000; 1: 1565-1571.
26. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class 1-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13: 399-408.
27. Edwards CQ, Griffen LM, Goldgar DE, Skolnick MH, Kushner JP. HLA-linked hemochromatosis alleles in sporadic porphyria cutanea tarda. Gastroenterology 1989; 97: 972-981.
28. Brady JJ, Jackson HA, Roberts AG, Morgan RR, Whatley SD, Rowlands GL, et al. Co-inheritance of mutations in the uroporphyrinogen decarboxylase and hemochromatosis genes accelerates the onset of porphyria cutanea tarda. J Invest Dermatol 2000; 115: 868-874.
29. Brunsting LA, Mason HL, Aldrich RA. Adult form of chronic porphyria with cutaneous manifestations. JAMA 1951; 146: 1207-1212.